The Promise of CAR NK Cell Therapy

Learn how scientists leverage the power of natural killer cells to fight cancer.

Roaming around the body is a group of natural killer (NK) cells that innately detect and destroy abnormal cells. In recent years, the success of chimeric antigen receptor (CAR) T cell therapy has brought the possibility of modifying NK cells into focus as a novel immunotherapeutic. In this webinar, Dean A. Lee will discuss the unique advantages of using NK cells for CAR therapy and the latest developments in their clinical utility.

Topics to be covered

  • CAR NK cells vs. CAR T cells
  • NK cell genetic engineering
  • Targets and applications of CAR NK cell therapy

Wednesday, September 14th, 2022 | 2:30 PM - 3:30 PM Eastern Time
This webinar will be available to view live and on demand.


Dean A. Lee, MD, PhD

Dean A. Lee, MD, PhD

Physician, Division of Hematology, Oncology, and BMT
Director, Cellular Therapy and Cancer Immunology Program
Nationwide Children's Hospital
The Ohio State University Comprehensive Cancer Center

Sponsored by